Back
EHRA Premium Access

Indexes of anticoagulation control and major adverse outcomes in patients with atrial fibrillation: an analysis from the AFFIRM Trial

Session: Poster session 3 - Atrial Fibrillation - Stroke Prevention
Topic: Oral Anticoagulation
Speaker: Doctor M. Proietti (Milan, IT)
Event: EHRA 2019

Congress Presentation

0

About the speaker

Doctor Marco Proietti

IRCCS Clinical Scientific Institute Maugeri, Milan (Italy)
6 presentations
0 follower

8 more presentations in this session

Quality of Anticoagulation Control and Major Adverse Outcomes in European Patients with Atrial Fibrillation: Analysis from EORP-AF General Long-Term Registry

Speaker: Doctor M. Proietti (Milan, IT)

Access
Abstract
Slides
0
Thumbnail

The influence of NOAC on sudden neurological death

Speaker: Doctor B. Slavchev (Sofia, BG)

Access
Abstract
Slides
0
Thumbnail

Ischemic stroke in patient with sinus node disease in comparison to atrial fibrillation, bradycardia-tachycardia syndrome and other cardiac conditions: a nationwide cohort-study

Speaker: Doctor A. Bodin (Tours, FR)

Access
Abstract
0
Thumbnail

Morpho-functional analysis of the left atrium appendage for stroke risk assessment in atrial fibrillation

Speaker: Doctor C. Tomasi (Ravenna, IT)

Access
Abstract
0
Thumbnail

Characteristics associated with death in patients with atrial fibrillation initiated on rivaroxaban and followed up for 1 year on treatment - an analysis in the pooled XANTUS data

Speaker: Professor J. Camm (London, GB)

Access
Abstract
0
Thumbnail

Access the full session

Poster session 3 - Atrial Fibrillation - Stroke Prevention

Speakers: Doctor M. Proietti, Doctor M. Proietti, Doctor B. Slavchev, Doctor A. Bodin, Doctor C. Tomasi...
Access
0
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk